Gentian Diagnostics ASA (OSL:GENT)
Norway · Delayed Price · Currency is NOK 44.00
-0.10 (-0.23%)
Apr 24, 2026, 4:25 PM CET
Gentian Diagnostics ASA Market Cap
Gentian Diagnostics ASA has a market cap or net worth of 680.18 million as of April 24, 2026. Its market cap has decreased by -4.95% in one year.
Market Cap
680.18M
Enterprise Value
597.24M
Revenue
176.50M
Ranking
n/a
PE Ratio
51.19
Stock Price
44.00
Market Cap Chart
Since December 14, 2016, Gentian Diagnostics ASA's market cap has increased from 289.62M to 680.18M, an increase of 134.85%. That is a compound annual growth rate of 9.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 680.18M | -21.80% |
| Dec 30, 2025 | 869.82M | 43.88% |
| Dec 30, 2024 | 604.56M | -5.54% |
| Dec 29, 2023 | 640.03M | 1.22% |
| Dec 30, 2022 | 632.32M | -43.06% |
| Dec 30, 2021 | 1.11B | 32.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 14, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.21B |
| Circio Holding ASA | 1.98B |
| Nordhealth AS | 1.89B |
| Photocure ASA | 1.85B |
| ArcticZymes Technologies ASA | 1.06B |
| Nykode Therapeutics AS | 1.04B |
| Vistin Pharma ASA | 997.75M |
| Omda AS | 838.76M |